CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 113 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,200,389 | +84.1% | 275,736 | +11.6% | 0.00% | +100.0% |
| Q2 2023 | $4,453,247 | -10.1% | 247,128 | -19.8% | 0.00% | 0.0% |
| Q1 2023 | $4,951,218 | +563.8% | 308,295 | +656.4% | 0.00% | – |
| Q4 2022 | $745,835 | -76.8% | 40,756 | -75.1% | 0.00% | -100.0% |
| Q3 2022 | $3,216,000 | +29.1% | 163,711 | +22.5% | 0.00% | 0.0% |
| Q2 2022 | $2,492,000 | +127.8% | 133,600 | +168.1% | 0.00% | – |
| Q1 2022 | $1,094,000 | -40.6% | 49,839 | -23.1% | 0.00% | – |
| Q4 2021 | $1,842,000 | +135.2% | 64,824 | +74.2% | 0.00% | – |
| Q3 2021 | $783,000 | -31.6% | 37,219 | -38.6% | 0.00% | – |
| Q2 2021 | $1,144,000 | +73.1% | 60,658 | +29.4% | 0.00% | – |
| Q4 2020 | $661,000 | +7.8% | 46,864 | +19.9% | 0.00% | – |
| Q3 2020 | $613,000 | +5.9% | 39,102 | +18.4% | 0.00% | – |
| Q2 2020 | $579,000 | +10.1% | 33,026 | -7.6% | 0.00% | – |
| Q1 2020 | $526,000 | -25.0% | 35,737 | +28.0% | 0.00% | – |
| Q4 2019 | $701,000 | +68.5% | 27,928 | +1.1% | 0.00% | – |
| Q3 2019 | $416,000 | +41.0% | 27,633 | +134.3% | 0.00% | – |
| Q2 2019 | $295,000 | – | 11,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |